Page 116 - 南京医科大学自然版

第44卷第7期
·1000 · 南 京 医 科 大 学 学 报 2024年7月

using needle biopsy and the potential role of in situ tissue cancer by promoting EMT［J］. Cancers，2020，12（10）：
microbiomes for promoting malignancy［J］. Front Oncol， 2728

2018，8：318 ［40］PARHI L，ALON⁃MAIMON T，SOL A，et al. Breast can⁃
［26］BANERJEE S，TIAN T，WEI Z，et al. Distinct microbial cer colonization by Fusobacterium nucleatum accelerates
signatures associated with different breast cancer types［J］. tumor growth and metastatic progression［J］. Nat Commun，
Front Microbiol，2018，9：951 2020，11（1）：3259
［27］WANG H，ALTEMUS J，NIAZI F，et al. Breast tissue，oral ［41］GERMAN R，MARINO N，HEMMERICH C，et al. Explor⁃
and urinary microbiomes in breast cancer［J］. Oncotarget， ing breast tissue microbial composition and the associa⁃
2017，8（50）：88122-88138 tion with breast cancer risk factors［J］. Breast cancer res，
［28］THOMPSON K J，INGLE J N，TANG X，et al. A compre⁃ 2023，25（1）：82
hensive analysis of breast cancer microbiota and host ［42］KEFAYAT A，GHAHREMANI F，MOTAGHI H，et al.
gene expression［J］. PloS One，2017，12（11）：e0188873 Alive attenuated Salmonella as a cargo shuttle for smart
［29］URBANIAK C，GLOOR G B，BRACKSTONE M，et al. carrying of gold nanoparticles to tumour hypoxic regions
The microbiota of breast tissue and its association with ［J］. J Drug Target，2019，27（3）：315-324
breast cancer［J］. Appl Environ Microbiol，2016，82（16）： ［43］JB R，V F，B L，et al. The role of microbial motility and
5039-5048 chemotaxis in symbiosis［J］. Nat Rev. Microbiol，2019，17
［30］HIEKEN T J，CHEN J，HOSKIN T L，et al. The microbi⁃ （5）：284-294
ome of aseptically collected human breast tissue in benign ［44］PLEGUEZUELOS⁃MANZANO C，PUSCHHOF J，HUBER
and malignant disease［J］. Sci Rep，2016，6：30751 A R，et al. Mutational signature in colorectal cancer
［31］ URBANIAK C，CUMMINS J，BRACKSTONE M，et al. caused by genotoxic pks（+）E. coli［J］. Nature，2020，580
Microbiota of human breast tissue［J］. Appl Environ （7802）：269-273
Microbiol，2014，80（10）：3007-3014 ［45］GOLDHIRSCH A，WINER E P，COATES A S，et al. Per⁃
［32］XUAN C，SHAMONKI J M，CHUNG A，et al. Microbial sonalizing the treatment of women with early breast cancer：
dysbiosis is associated with human breast cancer［J］. PloS highlights of the st gallen international expert consensus
One，2014，9（1）：e83744 on the primary therapy of early breast cancer 2013［J］.
［33］BARRETT M，HAND C K，SHANAHAN F，et al. Muta⁃ Ann Oncol，2013，24（9）：2206-2223
genesis by microbe：the role of the microbiota in shaping ［46］HUANG Z，YU K，XIAO Y，et al. Comparative genomic
the cancer genome［J］. Trends Cancer，2020，6（4）：277- analysis reveals potential pathogenicity and slow ⁃ growth
287 characteristics of genus Brevundimonas and description of
［34］LAI Y R，CHANG Y F，MA J，et al. From DNA damage to Brevundimonas pishanensis sp. nov［J］. Microbiol Spectr，
cancer progression：potential effects of cytolethal distend⁃ 2022，10（2）：e0246821
ing toxin［J］. Front Immunol，2021，12：760451 ［47］PARIDA S，SHARMA D. The power of small changes：
［35］DU L，SONG J. Delivery，structure，and function of bacte⁃ comprehensive analyses of microbial dysbiosis in breast
rial genotoxins［J］. Virulence，2022，13（1）：1199-1215 cancer［J］. Biochim Biophys Acta Rev Cancer，2019，1871
［36］WIEBE J P，MUZIA D，HU J，et al. The 4⁃pregnene and （2）：392-405
5alpha ⁃ pregnane progesterone metabolites formed in ［48］CHEN P，CHEN P，GUO Y，et al. Interaction between
nontumorous and tumorous breast tissue have opposite chronic endometritis caused endometrial microbiota disor⁃
effects on breast cell proliferation and adhesion［J］. Can⁃ der and endometrial immune environment change in
cer Res，2000，60（4）：936-943 recurrent implantation failure［J］. Front Immunol，2021，
［37］HUANG R，ZHOU P K. DNA damage repair：historical 12：748447
perspectives，mechanistic pathways and clinical transla⁃ ［49］BAUMGARTEN S C，FRASOR J. Minireview：Inflamma⁃
tion for targeted cancer therapy［J］. Signal Transduct Target tion：an instigator of more aggressive estrogen receptor
Ther，2021，6（1）：254 （ER）positive breast cancers［J］. Mol Endocrinol，2012，
［38］BRENNAN C A，GARRETT W S. Fusobacterium nuclea⁃ 26（3）：360-371
tum ⁃ symbiont，opportunist and oncobacterium［J］. Nat ［50］ROUTY B，LE CHATELIER E，DEROSA L，et al. Gut mi⁃
Rev Microbiol，2019，17（3）：156-166 crobiomeinfluencesefficacyofPD⁃1⁃basedimmunotherapy
［39］YU M R，KIM H J，PARK H R. Fusobacterium nucleatum against epithelial tumors［J］. Science，2018，359（6371）：

accelerates the progression of colitis⁃associated colorectal 91-97